Swope v. AstraZeneca Pharmaceuticals LP et al
Alfreda Swope |
MERCK & CO INC D/B/A MERCK, SHARP & DOHME CORPORATION, TAKEDA DEVELOPMENT CENTER AMERICAS INC. F/K/A TAKEDA GLOBAL RESEARCH & DEVELOPMENT CENTER INC, ASTRAZENECA LP, TAKEDA PHARMACEUTICAL COMPANY LIMITED, THE PROCTER & GAMBLE COMPANY, ASTRAZENECA PHARMACEUTICALS LP, PFIZER, INC., TAKEDA PHARMACEUTICALS U.S.A, INC., THE PROCTER & GAMBLE MANUFACTURING COMPANY and TAKEDA PHARMACEUTICALS AMERICA INC. |
PROTON-PUMP INHIBITOR PRODUCTS LIABILITY LITIGATION (No. II) |
2:2021cv00450 |
January 8, 2021 |
US District Court for the District of New Jersey |
Claire C Cecchi |
Mark Falk |
Personal Injury: Health Care/Pharmaceutical Personal Injury Product Liability |
28 U.S.C. § 1332 |
Plaintiff |
Docket Report
This docket was last retrieved on January 15, 2021. A more recent docket listing may be available from PACER.
Document Text |
---|
Filing 10 NOTICE of Appearance by KERRY CARSON GREEN on behalf of THE PROCTER & GAMBLE COMPANY, THE PROCTER & GAMBLE MANUFACTURING COMPANY (GREEN, KERRY) |
Filing 9 Clerk's Notice to Counsel. (gh, ) |
Filing 8 Certified Copy of Transfer Order and docket received, Case transferred in from District of Illinois Northern; Case Number 1:20-cv-07607. Original file certified copy of transfer order and docket sheet received. |
Judge Claire C. Cecchi and Chief Mag. Judge Mark Falk added. (gh, ) |
For all Case Management Orders #click here (gh, ) |
Member Case Transferred in on 1/8/21 from the Northern District of Illinois 1:20-cv-07607 for MDL 2789 PROTON-PUMP INHIBITOR PRODUCTS LIABILITY LITIGATION (No. II) (gh, ) |
Filing 7 TRANSFERRED to the USDC District of New Jersey the the electronic record. (mc, ) |
Filing 6 CONDITIONAL TRANSFER ORDER from MDL Panel transferring case to USDC District of New Jersey. Mailed notice(mc, ) |
***Civil Case Terminated pursuant to MDL (2789) Conditional Transfer Order filed 1/6/2021 (mc, ) |
Filing 5 MINUTE entry before the Honorable Robert M. Dow, Jr:Initial telephone conference is set for 1/29/2021 at 9:00 a.m. and parties are to report the following: (1) Possibility of settlement in the case; (2) If no possibility of settlement exists, the nature and length of discovery necessary to get the case ready for trial; (3) The report should include a proposed case management schedule reflecting any disputes between the parties as to the proposed schedule. Plaintiff is to advise all other parties of the Courts action herein. The parties are requested to file a joint status report at least THREE business days prior to the initial status and ALL further status hearings. For further details see the Court's website available at www.ilnd.uscourts.gov. Participants should use the Court's toll-free call-in number 877-336-1829, conference access code is 6963747. Emailed notice (cdh, ) |
Filing 4 MAILED Notice of Removal letter to counsel of record. (mc, ) |
Filing 3 CIVIL Cover Sheet (Maly, Heather) |
Filing 2 ATTORNEY Appearance for Defendants AstraZeneca LP, AstraZeneca Pharmaceuticals LP by Heather Lynn Maly (Maly, Heather) |
Filing 1 NOTICE of Removal from Circuit Court of Cook County, case number (2019L005974) filed by AstraZeneca LP, AstraZeneca Pharmaceuticals LP Filing fee $ 402, receipt number 0752-17763922. (Attachments: #1 Exhibit A1, #2 Exhibit A2, #3 Exhibit A3, #4 Exhibit B, #5 Exhibit C)(Maly, Heather) |
CASE ASSIGNED to the Honorable Robert M. Dow, Jr. Designated as Magistrate Judge the Honorable Jeffrey Cummings. Case assignment: Random assignment. (cp, ) |
Access additional case information on PACER
Use the links below to access additional information about this case on the US Court's PACER system. A subscription to PACER is required.
Access this case on the New Jersey District Court's Electronic Court Filings (ECF) System
- Search for Party Aliases
- Associated Cases
- Attorneys
- Case File Location
- Case Summary
- Docket Report
- History/Documents
- Parties
- Related Transactions
- Check Status
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.